US Federal 2025-2026 Regular Session

US Federal House Bill HB6117

Introduced
11/18/25  

Caption

Patient Device Data Access Act of 2025

Impact

If enacted, HB6117 would significantly enhance patient rights in terms of data access related to medical devices. Manufacturers would be required to provide detailed information about what specific data is being collected and how patients can access it. Additionally, manufacturers would need to inform patients if their device is subject to recalls, updates, or errors. This legislative change is anticipated to encourage manufacturers to develop better data-sharing practices and improve their communication with patients about device functionalities and safety.

Summary

House Bill 6117, known as the Patient Device Data Access Act of 2025, seeks to amend the Federal Food, Drug, and Cosmetic Act. The primary aim of this legislation is to mandate manufacturers of covered medical devices to disclose all patient-specific data that is recorded or transmitted by the devices and accessible to the manufacturers upon a patient’s request. This bill emphasizes the need for transparency and patient control over personal health data, ensuring patients who use such devices can access their own medical information easily. The provisions would cover a range of devices including those used for diagnosis, treatment, and remote monitoring.

Contention

Notably, the bill presents certain exceptions which prevent the Secretary from requiring manufacturers to disclose data that is recorded in closed systems or is otherwise inaccessible. This raises questions about the extent of transparency that can be achieved, as some critical patient data may still remain out of reach for patients. Furthermore, while the bill has garnered widespread support for its patient-centric approach, there may be concerns about the implications for manufacturers, such as increased compliance burdens and potential liability issues. Balancing patient data access with manufacturers' operational constraints will likely be a focal point of discussion as the bill progresses.

Companion Bills

No companion bills found.

Previously Filed As

US HB5605

Medical Device Nonvisual Accessibility Act of 2025

US HB5316

Drug Shortage Compounding Patient Access Act of 2025

US SB1717

Ensuring Patient Access to Critical Breakthrough Products Act of 2025

US HB4441

Patient Access to Innovative New Technologies Act of 2025

US HB5133

Patients’ Right to Know Their Medication Act of 2025

US HB5343

Ensuring Patient Access to Critical Breakthrough Products Act

US SB2372

340B PATIENTS Act of 2025 340B Pharmaceutical Access To Invest in Essential, Needed Treatments & Support Act of 2025

US HB4581

340B PATIENTS Act of 2025 340B Pharmaceutical Access To Invest in Essential, Needed Treatments & Support Act of 2025

US HB1931

Access to Pediatric Technologies Act of 2025

US SB882

Patients Before Middlemen Act

Similar Bills

CA SB561

An act to add Article 16 (commencing with Section 25258.

CA AB2747

Vehicles: manufacturers: engine labeling.

FL S0528

Manufacturing

NJ S1239

Creates "Manufacturing Reboot Program" in EDA to provide financial assistance to certain manufacturing businesses; makes $10 million appropriation to EDA.

NJ A2467

Creates "Manufacturing Reboot Program" in EDA to provide financial assistance to certain manufacturing businesses; makes $10 million appropriation to EDA.

CA AB2012

Vehicles: transportation of manufactured homes.

FL H0561

Manufacturing

FL S0600

Manufacturing